SiYi Intelligence, a Shangai, China-based intelligent rehabilitation solution provider, completed nearly USD15m in Series A financing.
The round was led by Chengdu Bio-town Equity Investment Fund with participation from existing investor Tao Capital.
The company plans to use the funding to accelerate the R&D of integration solutions for neurorehabilitation and build the digital rehabilitation service platform.
Established in 2017 and led by Gavin Yin, CEO, SiYi Intelligence specializes in the design, development and commercialization of cutting-edge solutions in rehabilitation. The company offers products and services for both clinical and home/community use. The portfolio includes SYREBO® soft robotic hand rehabilitation glove, EasyWalk exoskeleton walking suit for lower extremity augmentation, EEG-based assistive BCIs, and Transcutaneous Electrical Nerve Stimulation devices and accessories, etc. Leveraging an extensive distribution network, the products have been marketed globally in over 80 countries and regions, serving a huge customer base of 3000 clinics and 50,000 households.
To accelerate the implementation and verification of clinical rehabilitation theory, SiYi has carried out in-depth cooperation with Shanghai Jiao Tong University, Tohoku University in Japan, The Royal Buckinghamshire Hospital (RBH) in the UK, Manus Brescia Rehabilitation Center in Italy, Hongkong ShaTin Hospital and other international academic and medical institutions. By 2022, the company has over 30 authorized patents, over 50 registered trademarks, and more than 10 software copyrights.
FinSMEs
06/03/2023